Latest Breaking News On - Basilea pharmaceutica ltd - Page 5 : comparemela.com

Hospital Infection Therapeutics Market is to grow by USD 3 10 billion, Special drug designations to boost growth

/PRNewswire/ The hospital infection therapeutics market is estimated to grow by USD 3.10 billion from 2022 to 2027, growing at a CAGR of 4.98%, according to.

South koreaUnited statesSouth africaUnited kingdomJesse maidaCompany analysisCipla ltdBristol myers squibb coF hoffmann la roche ltdPfizer incTechnavio researchViatris incCompany profilesCompany landscapeBasilea pharmaceutica ltdAstrazeneca plc

Basilea Pharmaceutica AG: Cresemba® sales in Latin America trigger first sales milestone payment to Basilea

Basilea Pharmaceutica AG: Cresemba® sales in Latin America trigger first sales milestone payment to Basilea
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Basel stadtSwitzerland generalUnited statesNils schrStefan klotterDavid veitchBasilea pharmaceutica ltdKnight therapeutics incHead of corporate communications investor relationsSwiss exchangeEuropean unionBasilea pharmaceutica international ltdPharmaceutica ltdKnight therapeuticsLatin americaChief executive officer

Cresemba® sales in Latin America trigger first sales milestone payment to Basilea

Cresemba® sales in Latin America trigger first sales milestone payment to Basilea
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesBasel stadtDavid veitchNils schrSwiss exchangeKnight therapeutics incBasilea pharmaceutica ltdEuropean unionBasilea pharmaceutica international ltdHead of corporate communications investor relationsLatin americaPharmaceutica ltdKnight therapeuticsChief executive officerCorporate communications

Adhoc: Spexis AG: Spexis announces sale of preclinical antibiotics program to Basilea

Adhoc: Spexis AG: Spexis announces sale of preclinical antibiotics program to Basilea
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Basel stadtSwitzerland generalStephen jasperStephan feldhausCanton basel landschaftGilmartin groupUs department of healthHuman servicesAdministration for strategic preparednessSwiss exchangeNews serviceWorld health organizationBiomedical advanced researchDevelopment authorityGermany federal ministry of educationBasilea pharmaceutica ltd

Basilea Pharmaceutica AG: Basilea announces acquisition of preclinical antibiotics program from Spexis

Basilea Pharmaceutica AG: Basilea announces acquisition of preclinical antibiotics program from Spexis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtLaurenz kellenbergerCanton basel landschaftNils schrWorld health organizationSwiss exchangeHuman servicesAdministration for strategic preparednessBasilea pharmaceutica ltdGermany federal ministry of educationDistrict courtHead of corporate communications investor relationsBasilea pharmaceutica international ltdBiomedical advanced researchUs department of health